Chinese company BDGene from Shanghai continues to lead in the global race for a herpes keratitis cure. We reported on its progress – which it has published in the top international academic journals Nature Biotechnology and Nature Biomedical Engineering. Their gene editing treatment for viral keratitis (BD111), developed based on BDmRNA delivery patent technology, has completed 3 human clinicalContinue reading “BD Gene Presents data on possible Herpes Keratitis Cure”
Welcome to the latest clinical pipeline for Herpes Simplex Virus types 1 +2, the Herpes Cure Pipeline 3.0. Here we’ve updated, removed, and added new projects (preclinical research and in-human clinical trials) that have occurred over the last year, since the 2.0 edition was published in March 2022.
Want to help rally for a Herpes cure? Join for a live Rally to talk about the need for change.
We’re celebrating with the release of Herpes Cure Pipeline 3.0. Herpes Cure Advocacy is the only patient advocacy organization globally tracking the clinical pipeline for HSV. If you want to get the news first – please subscribe to our newsletter by clicking here today. Herpes Awareness Day Advocacy Alerts 1. White House Task Force forContinue reading “Herpes Awareness Day is October 13”
Hello advocates! We need you and your voice to help continue the momentum for change in Washington, DC. In order to do this, we’re looking for an advocate (or two!) in all fifty states. 50 State Challenge Willing to help? Please let us know where you live and the names of your elected representatives. FindContinue reading “50 State Challenge: Help us Find Advocates Across the US!”
Join hundreds of ID experts, HCPs, and patient advocates in the call for change. The White House 1600 Pennsylvania Avenue NW Washington, DC 20500 July 24, 2023 Dear President Biden, I am writing in support of a federal response to address the cure, treatment, and prevention of Herpes Simplex Virus in the United States. HerpesContinue reading “Call to Action: Group Letter to President Biden”
Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald September 20th 6pm EST Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the Department of Medicine, Epidemiology and Laboratory Medicine & Pathology at theContinue reading “Highlights from the Herpes Cure Pipeline with Dr. Anna Wald”
Hello, The Latest News in Herpes Advocacy is here. Enjoy reading the latest news? Want to see progress faster? Support our work today. Healthy Volunteers Needed for BNT163-01 Clinical Trial Healthy volunteers sought for clinical trial for herpes vaccine candidate from BioNtech BNT-163-01. Volunteers needed near The University of Pennsylvania Hospital in Philadelphia, PA. This isContinue reading “Updates from the Pipeline, IHW 2023 and more news!”
Advocates Town Hall Meeting: Herpes advocates town hall meetings are open to patients, professionals, and those looking to get involved to make a difference. We’ll discuss Herpes Cure Advocacy urgent priorities, a 90 day action plan for new advocates, and ways to get more involved. Please submit questions in advance at email@example.com. Thursday, June 1Continue reading “Register: Herpes Advocates Town Hall Meeting June 1”
Herpes Clinical Pipeline AiCuris Non-Confidential Slide Deck May 2023: AiCuris planning for commercial launch of Priteliver 2025. Launch prep for Priteliver is ongoing. Innovative Molecules advances IM-250: The clinical trial center in Heidelberg, Germany has Phase 2 clinical trials are scheduled for 2024. The clinical phase 1 study investigates the safety, tolerability, and pharmacokinetics ofContinue reading “Progress for a Cure for Herpes Continues”